| 000 | 00897 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250511160549.0 | ||
| 264 | 0 | _c19761002 | |
| 008 | 197610s 0 0 eng d | ||
| 022 | _a0003-0465 | ||
| 024 | 7 |
_a10.1016/s0003-0465(16)33659-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLewis, D F | |
| 245 | 0 | 0 |
_aPharmaceutical consequences of the European economic community. _h[electronic resource] |
| 260 |
_bJournal of the American Pharmaceutical Association _cJul 1976 |
||
| 300 |
_a406-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aEuropean Union |
| 650 | 0 | 4 | _aLegislation, Pharmacy |
| 650 | 0 | 4 | _aOrganization and Administration |
| 650 | 0 | 4 | _aPharmacy |
| 773 | 0 |
_tJournal of the American Pharmaceutical Association _gvol. 16 _gno. 7 _gp. 406-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0003-0465(16)33659-x _zAvailable from publisher's website |
| 999 |
_c957972 _d957972 |
||